The findings of this exploratory investigation warrant further large longitudinal or interventional studies, incorporating lifestyle changes, in larger and more diverse populations to verify the usefulness of ADRB3 genotyping in the prevention of NAFLD in the general population. The gene discussed is ADRB3; the disease is metabolic dysfunction-associated steatotic liver disease.